{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:10:21Z","timestamp":1794345021312,"version":"4.9.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004751","name":"Chinese Ministry of Science and Technology | Department of S and T for Social Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dopamine receptors are widely distributed in the central nervous system and are important therapeutic targets for treatment of various psychiatric and neurological diseases. Here, we report three cryo-electron microscopy structures of the D1 dopamine receptor (D1R)-Gs complex bound to two agonists, fenoldopam and tavapadon, and a positive allosteric modulator LY3154207. The structure reveals unusual binding of two fenoldopam molecules, one to the orthosteric binding pocket (OBP) and the other to the extended binding pocket (EBP). In contrast, one elongated tavapadon molecule binds to D1R, extending from OBP to EBP. Moreover, LY3154207 stabilizes the second intracellular loop of D1R in an alpha helical conformation to efficiently engage the G protein. Through a combination of biochemical, biophysical and cellular assays, we further show that the broad conformation stabilized by two fenoldopam molecules and interaction between TM5 and the agonist are important for biased signaling of D1R.<\/jats:p>","DOI":"10.1038\/s41467-022-30929-w","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T10:03:24Z","timestamp":1654682604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Ligand recognition and biased agonism of the D1 dopamine receptor"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5975-6254","authenticated-orcid":false,"given":"Xiao","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-3481","authenticated-orcid":false,"given":"Peng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1119-8334","authenticated-orcid":false,"given":"Xiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7204-801X","authenticated-orcid":false,"given":"Zhenhua","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7784-0177","authenticated-orcid":false,"given":"Sanduo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"30929_CR1","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/1801200a0","volume":"180","author":"A Carlsson","year":"1957","unstructured":"Carlsson, A., Lindqvist, M. & Magnusson, T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180, 1200 (1957).","journal-title":"Nature"},{"key":"30929_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1126\/science.127.3296.471.a","volume":"127","author":"A Carlsson","year":"1958","unstructured":"Carlsson, A., Lindqvist, M., Magnusson, T. & Waldeck, B. On the presence of 3-hydroxytyramine in brain. Science 127, 471 (1958).","journal-title":"Science"},{"key":"30929_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","volume":"63","author":"JM Beaulieu","year":"2011","unstructured":"Beaulieu, J. M. & Gainetdinov, R. R. The physiology, signaling, and pharmacology of dopamine receptors. Pharm. Rev. 63, 182\u2013217 (2011).","journal-title":"Pharm. Rev."},{"key":"30929_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","volume":"78","author":"C Missale","year":"1998","unstructured":"Missale, C., Nash, S. R., Robinson, S. W., Jaber, M. & Caron, M. G. Dopamine receptors: from structure to function. Physiol. Rev. 78, 189\u2013225 (1998).","journal-title":"Physiol. Rev."},{"key":"30929_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bph.12906","volume":"172","author":"JM Beaulieu","year":"2015","unstructured":"Beaulieu, J. M., Espinoza, S. & Gainetdinov, R. R. Dopamine receptors\u2014IUPHAR review 13. Br. J. Pharm. 172, 1\u201323 (2015).","journal-title":"Br. J. Pharm."},{"key":"30929_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0002-9343(84)80036-4","volume":"77","author":"LI Goldberg","year":"1984","unstructured":"Goldberg, L. I. Dopamine receptors and hypertension. Physiologic and pharmacologic implications. Am. J. Med 77, 37\u201344 (1984).","journal-title":"Am. J. Med"},{"key":"30929_CR7","first-page":"403039","volume":"2011","author":"S Hisahara","year":"2011","unstructured":"Hisahara, S. & Shimohama, S. Dopamine receptors and Parkinson\u2019s disease. Int J. Med Chem. 2011, 403039 (2011).","journal-title":"Int J. Med Chem."},{"key":"30929_CR8","first-page":"47","volume":"5","author":"R Brisch","year":"2014","unstructured":"Brisch, R. et al. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front. Psychiatry 5, 47 (2014).","journal-title":"Front. Psychiatry"},{"key":"30929_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/sj.mp.4001440","volume":"9","author":"VL Misener","year":"2004","unstructured":"Misener, V. L. et al. Linkage of the dopamine receptor D1 gene to attention-deficit\/hyperactivity disorder. Mol. Psychiatry 9, 500\u2013509 (2004).","journal-title":"Mol. Psychiatry"},{"key":"30929_CR10","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1056\/NEJMra010253","volume":"345","author":"MB Murphy","year":"2001","unstructured":"Murphy, M. B., Murray, C. & Shorten, G. D. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N. Engl. J. Med. 345, 1548\u20131557 (2001).","journal-title":"N. Engl. J. Med."},{"key":"30929_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1021\/acs.jmedchem.8b01767","volume":"62","author":"A Hall","year":"2019","unstructured":"Hall, A., Provins, L. & Valade, A. Novel strategies to activate the dopamine D1 receptor: recent advances in orthosteric agonism and positive allosteric modulation. J. Med. Chem. 62, 128\u2013140 (2019).","journal-title":"J. Med. Chem."},{"key":"30929_CR12","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1021\/acschemneuro.9b00410","volume":"10","author":"ML Martini","year":"2019","unstructured":"Martini, M. L. et al. Designing functionally selective noncatechol dopamine D1 receptor agonists with potent in vivo antiparkinsonian activity. ACS Chem. Neurosci. 10, 4160\u20134182 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"30929_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/med.20130","volume":"29","author":"J Zhang","year":"2009","unstructured":"Zhang, J., Xiong, B., Zhen, X. & Zhang, A. Dopamine D1 receptor ligands: where are we now and where are we going. Med. Res. Rev. 29, 272\u2013294 (2009).","journal-title":"Med. Res. Rev."},{"key":"30929_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11515-015-1360-4","volume":"10","author":"YC Kim","year":"2015","unstructured":"Kim, Y. C., Alberico, S. L., Emmons, E. & Narayanan, N. S. New therapeutic strategies targeting D1-type dopamine receptors for neuropsychiatric disease. Front. Biol. 10, 230\u2013238 (2015).","journal-title":"Front. Biol."},{"key":"30929_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0014-2999(96)00309-3","volume":"309","author":"PJ Blanchet","year":"1996","unstructured":"Blanchet, P. J., Grondin, R., Bedard, P. J., Shiosaki, K. & Britton, D. R. Dopamine D1 receptor desensitization profile in MPTP-lesioned primates. Eur. J. Pharm. 309, 13\u201320 (1996).","journal-title":"Eur. J. Pharm."},{"key":"30929_CR16","first-page":"339","volume":"21","author":"PJ Blanchet","year":"1998","unstructured":"Blanchet, P. J. et al. Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson\u2019s disease. Clin. Neuropharmacol. 21, 339\u2013343 (1998).","journal-title":"Clin. Neuropharmacol."},{"key":"30929_CR17","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1021\/acsmedchemlett.9b00050","volume":"10","author":"P Wang","year":"2019","unstructured":"Wang, P. et al. Synthesis and pharmacological evaluation of noncatechol G protein biased and unbiased dopamine D1 receptor agonists. ACS Med. Chem. Lett. 10, 792\u2013799 (2019).","journal-title":"ACS Med. Chem. Lett."},{"key":"30929_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02776-7","volume":"9","author":"DL Gray","year":"2018","unstructured":"Gray, D. L. et al. Impaired beta-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor. Nat. Commun. 9, 674 (2018).","journal-title":"Nat. Commun."},{"key":"30929_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/bs.apha.2019.06.001","volume":"86","author":"KA Svensson","year":"2019","unstructured":"Svensson, K. A., Hao, J. & Bruns, R. F. Positive allosteric modulators of the dopamine D1 receptor: a new mechanism for the treatment of neuropsychiatric disorders. Adv. Pharm. 86, 273\u2013305 (2019).","journal-title":"Adv. Pharm."},{"key":"30929_CR20","doi-asserted-by":"publisher","first-page":"127696","DOI":"10.1016\/j.bmcl.2020.127696","volume":"31","author":"KD Luderman","year":"2021","unstructured":"Luderman, K. D. et al. Development of pyrimidone D1 dopamine receptor positive allosteric modulators. Bioorg. Med. Chem. Lett. 31, 127696 (2021).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"30929_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s40120-018-0114-z","volume":"7","author":"US Sohur","year":"2018","unstructured":"Sohur, U. S. et al. Phase 1 Parkinson\u2019s disease studies show the dopamine D1\/D5 agonist PF-06649751 is safe and well tolerated. Neurol. Ther. 7, 307\u2013319 (2018).","journal-title":"Neurol. Ther."},{"key":"30929_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/cpdd.874","volume":"10","author":"D Wilbraham","year":"2021","unstructured":"Wilbraham, D., Biglan, K. M., Svensson, K. A., Tsai, M. & Kielbasa, W. Safety, tolerability, and pharmacokinetics of mevidalen (LY3154207), a centrally acting dopamine D1 receptor-positive allosteric modulator (D1PAM), in healthy subjects. Clin. Pharm. Drug Dev. 10, 393\u2013403 (2021).","journal-title":"Clin. Pharm. Drug Dev."},{"key":"30929_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1126\/science.1197410","volume":"330","author":"EY Chien","year":"2010","unstructured":"Chien, E. Y. et al. Structure of the human dopamine D3 receptor in complex with a D2\/D3 selective antagonist. Science 330, 1091\u20131095 (2010).","journal-title":"Science"},{"key":"30929_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1126\/science.aan5468","volume":"358","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. D4 dopamine receptor high-resolution structures enable the discovery of selective agonists. Science 358, 381\u2013386 (2017).","journal-title":"Science"},{"key":"30929_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature25758","volume":"555","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Nature 555, 269\u2013273 (2018).","journal-title":"Nature"},{"key":"30929_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14884-y","volume":"11","author":"L Fan","year":"2020","unstructured":"Fan, L. et al. Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands. Nat. Commun. 11, 1074 (2020).","journal-title":"Nat. Commun."},{"key":"30929_CR27","doi-asserted-by":"publisher","unstructured":"Zhou, Y., Cao, C., He, L., Wang, X. & Zhang, X. C. Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870. Elife 8. https:\/\/doi.org\/10.7554\/eLife.48822 (2019).","DOI":"10.7554\/eLife.48822"},{"key":"30929_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-020-2379-5","volume":"584","author":"J Yin","year":"2020","unstructured":"Yin, J. et al. Structure of a D2 dopamine receptor-G-protein complex in a lipid membrane. Nature 584, 125\u2013129 (2020).","journal-title":"Nature"},{"key":"30929_CR29","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.cell.2021.01.027","volume":"184","author":"Y Zhuang","year":"2021","unstructured":"Zhuang, Y. et al. Structural insights into the human D1 and D2 dopamine receptor signaling complexes. Cell 184, 931\u2013942 e918 (2021).","journal-title":"Cell"},{"key":"30929_CR30","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.molcel.2021.01.003","volume":"81","author":"P Xu","year":"2021","unstructured":"Xu, P. et al. Structures of the human dopamine D3 receptor-Gi complexes. Mol. Cell 81, 1147\u20131159 e1144 (2021).","journal-title":"Mol. Cell"},{"key":"30929_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23519-9","volume":"12","author":"B Sun","year":"2021","unstructured":"Sun, B. et al. Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist. Nat. Commun. 12, 3305 (2021).","journal-title":"Nat. Commun."},{"key":"30929_CR32","doi-asserted-by":"publisher","unstructured":"Zhuang, Y. et al. Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor. Cell Res. https:\/\/doi.org\/10.1038\/s41422-021-00482-0 (2021).","DOI":"10.1038\/s41422-021-00482-0"},{"key":"30929_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cell.2021.01.028","volume":"184","author":"P Xiao","year":"2021","unstructured":"Xiao, P. et al. Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes. Cell 184, 943\u2013956.e918 (2021).","journal-title":"Cell"},{"key":"30929_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-021-00630-3","volume":"6","author":"DR Sibley","year":"2021","unstructured":"Sibley, D. R., Luderman, K. D., Free, R. B. & Shi, L. Novel Cryo-EM structures of the D1 dopamine receptor unlock its therapeutic potential. Signal Transduct. Target Ther. 6, 205 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"30929_CR35","doi-asserted-by":"crossref","unstructured":"Teng, X. et al. Structural insights into G protein activation by D1 dopamine receptor. BioRxiv (2022).","DOI":"10.1101\/2022.01.18.476830"},{"key":"30929_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature10361","volume":"477","author":"SG Rasmussen","year":"2011","unstructured":"Rasmussen, S. G. et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 477, 549\u2013555 (2011).","journal-title":"Nature"},{"key":"30929_CR37","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1074\/jbc.RA118.001975","volume":"293","author":"Q Wan","year":"2018","unstructured":"Wan, Q. et al. Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells. J. Biol. Chem. 293, 7466\u20137473 (2018).","journal-title":"J. Biol. Chem."},{"key":"30929_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ceb.2014.01.008","volume":"27","author":"A Manglik","year":"2014","unstructured":"Manglik, A. & Kobilka, B. The role of protein dynamics in GPCR function: insights from the beta2AR and rhodopsin. Curr. Opin. Cell Biol. 27, 136\u2013143 (2014).","journal-title":"Curr. Opin. Cell Biol."},{"key":"30929_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1021\/acs.chemrev.6b00177","volume":"117","author":"NR Latorraca","year":"2017","unstructured":"Latorraca, N. R., Venkatakrishnan, A. J. & Dror, R. O. GPCR dynamics: structures in motion. Chem. Rev. 117, 139\u2013155 (2017).","journal-title":"Chem. Rev."},{"key":"30929_CR40","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cell.2018.12.005","volume":"176","author":"LM Wingler","year":"2019","unstructured":"Wingler, L. M. et al. Angiotensin analogs with divergent bias stabilize distinct receptor conformations. Cell 176, 468\u2013478.e411 (2019).","journal-title":"Cell"},{"key":"30929_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymeth.2012.12.005","volume":"59","author":"SA Seidel","year":"2013","unstructured":"Seidel, S. A. et al. Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions. Methods 59, 301\u2013315 (2013).","journal-title":"Methods"},{"key":"30929_CR42","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.cell.2019.04.044","volume":"177","author":"A Inoue","year":"2019","unstructured":"Inoue, A. et al. Illuminating G-protein-coupling selectivity of GPCRs. Cell 177, 1933\u20131947.e1925 (2019).","journal-title":"Cell"},{"key":"30929_CR43","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nsmb.3014","volume":"22","author":"WK Kroeze","year":"2015","unstructured":"Kroeze, W. K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362\u2013369 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"30929_CR44","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2019.03.036","volume":"177","author":"H Chen","year":"2019","unstructured":"Chen, H. et al. A forward chemical genetic screen reveals gut microbiota metabolites that modulate host physiology. Cell 177, 1217\u20131231.e1218 (2019).","journal-title":"Cell"},{"key":"30929_CR45","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1021\/acs.jmedchem.9b00351","volume":"62","author":"ML Martini","year":"2019","unstructured":"Martini, M. L. et al. Defining structure-functional selectivity relationships (SFSR) for a class of non-catechol dopamine D1 receptor agonists. J. Med. Chem. 62, 3753\u20133772 (2019).","journal-title":"J. Med. Chem."},{"key":"30929_CR46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1021\/acschemneuro.5b00020","volume":"6","author":"JL Conroy","year":"2015","unstructured":"Conroy, J. L., Free, R. B. & Sibley, D. R. Identification of G protein-biased agonists that fail to recruit beta-arrestin or promote internalization of the D1 dopamine receptor. ACS Chem. Neurosci. 6, 681\u2013692 (2015).","journal-title":"ACS Chem. Neurosci."},{"key":"30929_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41594-017-0011-7","volume":"25","author":"D Hilger","year":"2018","unstructured":"Hilger, D., Masureel, M. & Kobilka, B. K. Structure and dynamics of GPCR signaling complexes. Nat. Struct. Mol. Biol. 25, 4\u201312 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"30929_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.neuropharm.2014.05.042","volume":"86","author":"SM Lee","year":"2014","unstructured":"Lee, S. M. et al. SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C. Neuropharmacology 86, 145\u2013154 (2014).","journal-title":"Neuropharmacology"},{"key":"30929_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0014-2999(83)90381-3","volume":"91","author":"J Hyttel","year":"1983","unstructured":"Hyttel, J. SCH 23390\u2014the first selective dopamine D-1 antagonist. Eur. J. Pharm. 91, 153\u2013154 (1983).","journal-title":"Eur. J. Pharm."},{"key":"30929_CR50","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1126\/science.aaw8981","volume":"364","author":"X Liu","year":"2019","unstructured":"Liu, X. et al. Mechanism of beta2AR regulation by an intracellular positive allosteric modulator. Science 364, 1283\u20131287 (2019).","journal-title":"Science"},{"key":"30929_CR51","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41586-020-2419-1","volume":"583","author":"Y Lee","year":"2020","unstructured":"Lee, Y. et al. Molecular basis of beta-arrestin coupling to formoterol-bound beta1-adrenoceptor. Nature 583, 862\u2013866 (2020).","journal-title":"Nature"},{"key":"30929_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14889-7","volume":"11","author":"T Che","year":"2020","unstructured":"Che, T. et al. Nanobody-enabled monitoring of kappa opioid receptor states. Nat. Commun. 11, 1145 (2020).","journal-title":"Nat. Commun."},{"key":"30929_CR53","doi-asserted-by":"publisher","unstructured":"Jakubik, J. & El-Fakahany, E. E. Allosteric modulation of GPCRs of class A by cholesterol. Int. J. Mol. Sci. 22. https:\/\/doi.org\/10.3390\/ijms22041953 (2021).","DOI":"10.3390\/ijms22041953"},{"key":"30929_CR54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12735","volume":"504","author":"AC Kruse","year":"2013","unstructured":"Kruse, A. C. et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature 504, 101\u2013106 (2013).","journal-title":"Nature"},{"key":"30929_CR55","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-019-0990-0","volume":"567","author":"S Zheng","year":"2019","unstructured":"Zheng, S., Abreu, N., Levitz, J. & Kruse, A. C. Structural basis for KCTD-mediated rapid desensitization of GABAB signalling. Nature 567, 127\u2013131 (2019).","journal-title":"Nature"},{"key":"30929_CR56","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"30929_CR57","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"30929_CR58","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"30929_CR59","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"30929_CR60","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"30929_CR61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D. Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"30929_CR62","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/nmeth.3541","volume":"12","author":"BA Barad","year":"2015","unstructured":"Barad, B. A. et al. EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy. Nat. Methods 12, 943\u2013946 (2015).","journal-title":"Nat. Methods"},{"key":"30929_CR63","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1124\/mol.111.072801","volume":"80","author":"S Rajagopal","year":"2011","unstructured":"Rajagopal, S. et al. Quantifying ligand bias at seven-transmembrane receptors. Mol. Pharm. 80, 367\u2013377 (2011).","journal-title":"Mol. Pharm."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30929-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30929-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30929-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:28:22Z","timestamp":1669310902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30929-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["30929"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-30929-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,8]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3186"}}